The Decro Pharma manufacturing plant at Indrad

Manufacturing facilities

Where we make it.

Our plant sits at Plot No. 7, Umiya Industrial Estate, Indrad — about half an hour from Ahmedabad. It was designed and is run by a skilled, experienced team, and built to meet the standards of both Indian and global regulators.

What's on site

Six areas, under one roof.

BLOCK A

Bulk API manufacturing

Where we make our bulk active ingredients — the B12 family, plus our heart and metabolic actives — each on its own dedicated, contained line.

BLOCK B

Sterile & freeze-drying

Our clean sterile core, with freeze-dryers that stopper vials inside the chamber. We develop and validate the cycles ourselves, and keep everything sterile from fill to finish.

BLOCK C

Filling lines

Our lines for dry-powder injections and liquid injections, filling anything from 2 ml ampoules up to 100 ml vials.

QC · GLP

Quality control lab

Our own GLP lab checks identity, strength, sterility and stability, and signs off every batch against BP, USP, EP, IP and JP standards.

R&D

Research & development

Our scientists keep improving how we make things — refining routes and freeze-drying cycles to be safer, greener and better value.

STORES

Storage & dispatch

Temperature-controlled stores for raw materials and finished goods, and dispatch that's ready for cold-chain shipments at home and abroad.

An analyst at a microscope in the quality control laboratory
QC bench
Gloved hands inspecting a finished tablet under clean conditions
In-process check
Filled injection vials arranged beside a syringe
Finished vials

We're happy to show you around or host an audit visit — just get in touch to arrange a time.

What we do best

Lyophilisation is our strong suit.

It's written into our mission statement, and for good reason. Freeze-drying is the hardest way to keep a sterile drug stable — and it's why a Decro vial still mixes cleanly at a hospital years after it leaves Indrad. Here's how it works.

  1. 01

    Freeze

    −45.0 °C

    Shelf temperature

    The solution is cooled well below freezing on tightly controlled shelves, so the drug sets into a stable, solid form.

  2. 02

    Vacuum

    0.081 mBar

    Chamber pressure

    Pressure drops to a fraction of a millibar. Under a vacuum this deep, the ice can't melt — it can only turn straight to vapour.

  3. 03

    Sublimate

    −20.0 °C

    Primary drying

    Over primary and secondary drying, the water leaves bit by bit, leaving behind a dry cake that dissolves the moment it's needed.

  4. 04

    Seal

    +25.0 °C

    Stoppered under N₂

    Vials are stoppered under nitrogen and sealed right there in the chamber, so they stay sterile from fill to finish.

Rows of sealed vials holding lyophilised product

The result · sterile lyophilised vials

A stable, dry cake that mixes back cleanly the moment it's reconstituted.

Standards & compliance

Held to Indian and global standards.

Our facility is designed, documented and audited against every framework below — the State FDA and CDSCO at home, and WHO-GMP, EU-GMP and PIC/S for the markets we export to. Every batch is released through our own GLP quality-control lab.

  1. 01

    WHO cGMP

    World Health Organization current Good Manufacturing Practices

  2. 02

    EU GMP

    European Union Good Manufacturing Practice guidelines

  3. 03

    PIC/S

    Pharmaceutical Inspection Co-operation Scheme guidelines

  4. 04

    Schedule M

    Indian GMP requirements under the Drugs & Cosmetics Rules

  5. 05

    GLP

    Good Laboratory Practices across quality control

  6. 06

    CDSCO

    Central Drugs Standard Control Organisation, India

  7. Need certificate scopes or an audit pack? We send them with every quotation — just email sales@decropharma.com.

Get in touch

Looking for a manufacturing partner?

Whether you need bulk APIs, finished injectables or contract manufacturing, tell us what you're after — in India or abroad — and we'll come back with specs, pricing and lead times.